Back | Next |
home / stock / vyne / vyne message board
Subject | By | Source | When |
---|---|---|---|
Yeah, I can live with that! | artfulife | investorshub | 10/07/2020 11:59:45 PM |
I dunno... At $7.75/shares we'd be limiting ourselves | jugs | investorshub | 10/07/2020 11:45:21 PM |
From Reza Ganjavi's blog | artfulife | investorshub | 10/07/2020 11:28:04 PM |
https://www.modernreaders.com/news/2020/10/06/goldman-sachs-group-inc-purchases- | Billr05 | investorshub | 10/06/2020 12:25:33 PM |
H.C. Wainwright raises $VYNE Therapeutics target | Billr05 | investorshub | 10/05/2020 7:48:04 PM |
https://vynetherapeutics.com/press-releases/vyne-therapeutics-announces-zilxi-mi | Billr05 | investorshub | 10/01/2020 2:34:26 PM |
better direct link instead of via twitter | realfast95 | investorshub | 09/24/2020 5:37:34 PM |
Love the analysis. I will dig into a | Estoril | investorshub | 09/24/2020 5:13:37 PM |
Interesting morning today with $VYNE higher by 20 | jugs | investorshub | 09/24/2020 4:56:10 PM |
VYNE's Current Market Cap Presents An Attractive Opportunity | realfast95 | investorshub | 09/24/2020 3:02:07 PM |
Yes. I've been in this since the old | jugs | investorshub | 09/24/2020 2:35:03 PM |
Have you done any DD or looked at | Estoril | investorshub | 09/24/2020 2:24:43 PM |
Absolutely so! | jugs | investorshub | 09/24/2020 2:03:04 PM |
Interesting developments... If you likes it at 1.69 | Estoril | investorshub | 09/24/2020 1:50:54 PM |
Looks like someone was accumulating and then quit | pickspicks1 | investorshub | 09/24/2020 10:20:23 AM |
My take is that people are losing faith | jugs | investorshub | 09/23/2020 7:02:16 PM |
WTF? | pickspicks1 | investorshub | 09/23/2020 6:35:52 PM |
Added a couple thousand today. We seem | pickspicks1 | investorshub | 09/22/2020 1:52:41 PM |
While the DJIA is down nearly 900 points, | jugs | investorshub | 09/21/2020 3:41:05 PM |
Just now noticed that $VYNE gained 21% over | jugs | investorshub | 09/19/2020 4:07:29 PM |
News, Short Squeeze, Breakout and More Instantly...
VYNE Therapeutics Inc Com Company Name:
VYNE Stock Symbol:
NASDAQ Market:
Design of Phase 2b trial for VYN201 in nonsegmental vitiligo finalized and on track to begin this quarter Phase 2b trial expected to enroll approximately 160 subjects with either active or stable nonsegmental vitiligo and will evaluate VYN201 gel in 1%, 2% and 3% concentrations compared t...
In preclinical studies, VYN202 achieved consistent reductions in pro-inflammatory and disease-related biomarkers and improvements in disease severity across a variety of inflammatory and fibrotic models Phase 1a SAD/MAD trial expected to start this quarter BRIDGEWATER, N.J., May 0...
Presentations will highlight positive preclinical and Phase 1b data of novel BET inhibitor, VYN201, in nonsegmental vitiligo BRIDGEWATER, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage ...